» Authors » Emoke Deschmann

Emoke Deschmann

Explore the profile of Emoke Deschmann including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 104
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Houben N, Fustolo-Gunnink S, Fijnvandraat K, Caram-Deelder C, Aguar Carrascosa M, Beuchee A, et al.
Arch Dis Child Fetal Neonatal Ed . 2025 Jan; PMID: 39832820
Objective: Despite lack of evidence supporting efficacy, prophylactic fresh frozen plasma and Octaplas transfusions may be administered to very preterm infants to reduce bleeding risk. International variation in plasma transfusion...
2.
Houben N, Lopriore E, Fijnvandraat K, Caram-Deelder C, Aguar Carrascosa M, Beuchee A, et al.
Lancet Reg Health Eur . 2024 Dec; 47:101086. PMID: 39669406
Background: Platelet transfusions are given to preterm infants with severe thrombocytopenia aiming to prevent haemorrhage. The PlaNeT2/MATISSE trial revealed higher rates of mortality and/or major bleeding in preterm infants receiving...
3.
Houben N, Fustolo-Gunnink S, Fijnvandraat K, Caram-Deelder C, Aguar Carrascosa M, Beuchee A, et al.
JAMA Netw Open . 2024 Sep; 7(9):e2434077. PMID: 39298172
Importance: Red blood cell (RBC) transfusions are frequently administered to preterm infants born before 32 weeks of gestation in the neonatal intensive care unit (NICU). Two randomized clinical trials (Effects...
4.
Reibel-Georgi N, Scrivens A, Heeger L, Lopriore E, New H, Deschmann E, et al.
J Pediatr . 2024 Sep; 276:114302. PMID: 39277077
Objectives: To survey practices of iron and recombinant human erythropoietin (rhEpo) administration to infants born preterm across Europe. Study Design: Over a 3-month period, we conducted an online survey in...
5.
Deschmann E, Dame C, Sola-Visner M, Fustolo-Gunnink S, Guyatt G, Patel R, et al.
JAMA Netw Open . 2024 Jun; 7(6):e2417431. PMID: 38874929
Importance: Red blood cell (RBC) transfusion is a common medical intervention to treat anemia in very preterm neonates; however, best transfusion practices, such as thresholds, remain uncertain. Objective: To develop...
6.
Cortesi V, Cavallaro G, Raffaeli G, Ghirardello S, Mosca F, Klei T, et al.
Blood Transfus . 2024 Apr; 22(4):292-302. PMID: 38557319
Thrombocytopenia (defined as a platelet count <150×10/L) is a common condition in preterm neonates and may occur in 18-35% of all infants admitted to the Neonatal Intensive Care Unit (NICU)....
7.
Scrivens A, Reibel N, Heeger L, Stanworth S, Lopriore E, New H, et al.
Arch Dis Child Fetal Neonatal Ed . 2023 Jan; 108(4):360-366. PMID: 36653173
Background: Preterm infants commonly receive red blood cell (RBC), platelet and fresh frozen plasma (FFP) transfusions. The aim of this Neonatal Transfusion Network survey was to describe current transfusion practices...
8.
de Vos T, Winkelhorst D, Arnadottir V, van der Bom J, Canals Suris C, Caram-Deelder C, et al.
Lancet Haematol . 2022 Sep; 9(11):e844-e853. PMID: 36108655
Background: Children affected by fetal and neonatal alloimmune thrombocytopenia (FNAIT) are at risk of severe intracranial haemorrhage. Management in the postnatal period is based on sparse evidence. We aimed to...
9.
Liu Z, Deschmann E, Ramsey H, Feldman H, Psaila B, Cooper N, et al.
Blood Adv . 2021 Oct; 6(1):13-27. PMID: 34654056
Eltrombopag (ELT) is a thrombopoietic agent approved for immune thrombocytopenia and also a potent iron chelator. Here we found that ELT exhibited dose-dependent opposing effects on in vitro megakaryopoiesis: low...
10.
Deschmann E, Andersson A, Frisk T, Magnusson M
Lakartidningen . 2021 Mar; 118. PMID: 33754331
Transfusions should be given for medical indications and based on the clinical context for the individual patient. Clinicians should follow the most current existing clinical guidelines. The neonatal hemostatic system...